PharMEDium Services LLC has recalled 55 lots of compounded drug products due to a lack of sterility assurance, the Food and Drug Administration announced last week. The products were distributed to U.S. hospitals and clinics. Customers with recalled products should immediately quarantine and destroy them, and may report associated adverse reactions or quality problems to the FDA's MedWatch program.

Related News Articles

Headline
The Centers for Medicare…
Headline
The AHA’s Institute for Diversity and Health Equity today named Duane Elliott Reynolds as its new president and CEO.
Blog
Axios' The poor state of U.S hospital quality (December 1, 2018) gives an incomplete view on the state of quality and safety in America’s hospitals and health…
Headline
The Food and Drug Administration yesterday released revised draft guidance for facilities that compound human drugs as outsourcing facilities.
Headline
Inpatient rehabilitation facilities and long-term care hospitals have until Jan. 2 to review confidential provider reports based on quality data from second-…
Headline
The Institute for Healthcare Improvement today released a white paper intended to help health system boards assess and improve their quality oversight…